Dr. Michael Olek, DO – Henderson, NV
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
Chen JA, Barkoff F, Comi G, TRANSFORMS Study Group-Olek MJ, NEJM, 1/4/2010Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
Radue EW, Stuart WH, Calabresi PA, SENTINEL Investigators-Olek MJ, J Neurol Sci, 1/1/2010Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis
Zhang Y, Da RR, Guo W, Ren HM, Hilgenberg LG, Sobel RA, Tourtellotte WW, Smith MA, Olek M, Gupta S, Robertson RT, Nagra R, Van Den Noort S, Qin Y., J Clin Immunol, 1/1/2005
